Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PLC Systems, a medical technology company, has entered into a five year exclusive agreement with Izasa Distribuciones Tecnicas, a Spanish distributor of interventional cardiology-related medical devices, for distribution of its RenalGuard System into Spain.
Subscribe to our email newsletter
Izasa will target early adopters who recognize the benefits of utilizing the unique fluid balancing capabilities of RenalGuard in a cath lab setting during cardiovascular imaging procedures for patients at higher risk of contrast-induced nephropathy.
An investigator-sponsored randomized clinical trial to evaluate the use of RenalGuard in the prevention of contrast-induced nephropathy is currently underway in Italy.
Mark Tauscher, president and CEO of PLC Systems, said: “We are extremely pleased with our new agreement with Izasa in Spain. This firm’s strong penetration of the leading cardiovascular centers in Spain will help expose the benefits of RenalGuard to a wider community of physicians.”